Author:
Carmo-Pereira J.,Costa F. O.,Miles D. W.,Henriques E.,Richards M. A.,Rubens R. D.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference8 articles.
1. Bronchud MH, Howell A, Crowther D, Hopwood P, Souza L, Dexter TM (1989) The use of granulocyte colony-stimulting factor to increaase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer. Br J Cancer 60: 121?125
2. Carmo-Pereira J, Costa FO, Henriques E, Godinho R, Cantinho-Lopes G, Sales-Luis A, Rubens RD (1987) A comparison of two doses of Adriamycon in the primary chemotherapy of disseminated breast carcinoma. Br J Cancer 56: 471?473
3. Hayward JL, Rubens RD, Carbone PP, Heuson J-C, Kumaoka S, Segaloff A (1977) Assessment of response to therapy in advanced breast cancer. Br J Cancer 35: 292?298
4. Henderson C, Hayes D, Come S, Harris J, Canellos G (1987) New agents and new medical treatments for advanced breast cancer. Semin Oncol 14: 34?64
5. Hryniuk WM (1987) Average relative dose intensity and the impact on design of clinical trials. Semin Oncol 14: 65?74